FDA grant to WHO addresses counterfeiting
This article was originally published in The Tan Sheet
FDA plans to award the World Health Organization $960,500 to build a global surveillance and monitoring system to root out counterfeit medicines, according to an Oct. 13 Federal Register notice. WHO would use the grant, requested in a single-source 1application, to identify risks in supply chains, standardize data collection among member states and harmonize analyses to identify counterfeit medicines. FDA may extend the grant, which will be from the agency's fiscal 2010 appropriation, for three more years for up to $847,500 annually
You may also be interested in...
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.
Agency has been prepping Woodcock for the temporary task but what will happen to her role on Operation Warp Speed remains unclear. The move should give Biden team cushion to confirm a permanent leader of whom a top contender is former senior FDA staffer Joshua Sharfstein, a proponent of drug reforms that may irk manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.